In an era characterized by unprecedented change and technological advancement, the message from industry leaders is clear: digital transformation is no longer optional but a critical necessity for survival and growth.
In this MDIC Studio session, hear from Daniel Matlis, President and Founder of Axendia, as he describes the current state of advanced manufacturing in the life sciences industry and what is yet to come. Matlis offers a comprehensive overview of how novel and innovative applications of existing technologies are reshaping manufacturing processes to enhance product quality and improve patient outcomes. Drawing from Axendia’s extensive primary research and interactions with regulatory officials, industry executives, and clients, Matlis discusses the current landscape and the critical need for broadening the adoption of advanced manufacturing technologies throughout the total product lifecycle.
“We’re living in the age of continuous disruption as and as organizations. We need to realize and prepare for that. And as a result, digital transformation. It’s not a nice to have. It is an imperative for our industry.” As the pace of technological change shows no signs of slowing, the importance of digital transformation will only grow. Companies that embrace this shift will be better positioned to navigate disruptions, meet customer needs, and drive sustainable growth.
Daniel’s insights serve as a reminder that in the age of continuous disruption, digital transformation is not just a strategy but a fundamental requirement. Organizations that recognize this imperative and act accordingly will be the ones that thrive in the digital future.
We invite you to learn more about the Advanced Manufacturing Clearing House and reach out to us with questions about how you can participate at AMCH@MDIC.org.
